Simulations Plus, Inc.

NASDAQ:SLP

30.59 (USD) • At close November 8, 2024
Bedrijfsnaam Simulations Plus, Inc.
Symbool SLP
Munteenheid USD
Prijs 30.59
Beurswaarde 613,855,648
Dividendpercentage 0.49%
52-weken bereik 27.22 - 51.22
Industrie Health Information Services
Sector Healthcare
CEO Mr. Walter S. Woltosz M.A.S., M.S.
Website https://www.simulations-plus.com

An error occurred while fetching data.

Over Simulations Plus, Inc.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of

Vergelijkbare Aandelen

Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc.

RXRX

7.1 USD

SNDL Inc. logo

SNDL Inc.

SNDL

1.98 USD

Ventyx Biosciences, Inc. logo

Ventyx Biosciences, Inc.

VTYX

2.2 USD

BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc.

BBIO

27.09 USD

Varex Imaging Corporation logo

Varex Imaging Corporation

VREX

14.22 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)